Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) FCF Margin (2016 - 2026)

Mimedx's FCF Margin history spans 16 years, with the latest figure at 2.22% for Q1 2026.

  • On a quarterly basis, FCF Margin fell 336.0% to 2.22% in Q1 2026 year-over-year; TTM through Mar 2026 was 17.81%, a 79.0% decrease, with the full-year FY2025 number at 17.43%, down 133.0% from a year prior.
  • FCF Margin hit 2.22% in Q1 2026 for Mimedx, down from 20.89% in the prior quarter.
  • Over the last five years, FCF Margin for MDXG hit a ceiling of 25.96% in Q2 2024 and a floor of 17.56% in Q1 2022.
  • Historically, FCF Margin has averaged 9.15% across 5 years, with a median of 9.2% in 2023.
  • Biggest five-year swings in FCF Margin: surged 2741bps in 2022 and later tumbled -1152bps in 2025.
  • Tracing MDXG's FCF Margin over 5 years: stood at 4.88% in 2022, then soared by 95bps to 9.52% in 2023, then skyrocketed by 120bps to 20.93% in 2024, then dropped by 0bps to 20.89% in 2025, then plummeted by -89bps to 2.22% in 2026.
  • Business Quant data shows FCF Margin for MDXG at 2.22% in Q1 2026, 20.89% in Q4 2025, and 25.62% in Q3 2025.